Received Apr 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | IM / LA |
Dizzy spells; This non-serious case was reported by a consumer via call center representative and described the occurrence of dizzy spells in a 65-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 04-APR-2025, the patient received Shingles vaccine (intramuscular, left deltoid) .5 ml. On 04-APR-2025, 4 hrs after receiving Shingles vaccine, the patient experienced dizzy spells (Verbatim: Dizzy spells). The outcome of the dizzy spells was not resolved. It was unknown if the reporter considered the dizzy spells to be related to Shingles vaccine. It was unknown if the company considered the dizzy spells to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 10-APR-2025 The reporter was a patient's husband. The reporter states that the patient started having intermittent episodes of dizziness approximately 4 hours after receiving suspect vaccine. Dizzy spells were ongoing, and patient was seeing her physician at the time of reporting.